According to IMARC Group’s latest report, titled “China Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ the China genetic testing market reached a value of US$ 2.76 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 16.8% during 2021-2026.
Genetic testing provides an accurate determination of bloodline and diagnosis of vulnerabilities to diseases, which can be inherited by determining changes in chromosomes, genes, and proteins. The results can rule out or confirm and help identify the patient’s chance of passing or developing a genetic disorder in laboratory settings. The testing also enables the early diagnosis of chronic diseases, which helps in timely treatment and prevention.
Request for a PDF sample of this report: https://www.imarcgroup.com/china-genetic-testing-market/requestsample
China Genetic testing Market Trends:
The growing cases of genetic disorders and the increasing consumer awareness regarding the early detection of various chronic diseases is primarily driving the market growth in China. In line with this, the availability of direct-to-consumer genetic testing (DTC-GT) kits and the inflating consumer expenditure power are providing a significant boost to the market growth. Moreover, favorable initiatives undertaken by the Government of the People’s Republic of China to sensitize the masses about genetic testing are supporting the market growth. In addition, the burgeoning investments in research and development (R&D) activities, rapid technological advancements to reduce the costs of deoxyribonucleic acid (DNA) sequencing services, and the extensive utilization of the method in drug-gene testing for producing personalized medicines are creating a positive outlook for the market in the country.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Competitive Landscape:
- BGI
- Berry Genomics Co. ltd.
- Daan Gene Co. Ltd
- WuXi NextCODE
- Annoroad Gene Technology Co. Ltd.
- WuXi PharmaTech
Breakup by Test Type:
- Prenatal Testing
- Carrier Testing
- New Born Testing
- Predictive/Presymptomatic Testing
- Diagnostic Testing
- Others
Breakup by Disease:
- Cancer
- Down Syndrome
- Thalassemia
- Others
Breakup by Technology:
- Biochemical
- Molecular
- Cytogenetic
Breakup by Service Provider:
- Hospital Based Laboratories
- Independent Laboratories
- Specialty Clinics
Breakup by Testing Sample:
- Blood
- Saliva
- Hair
- Others
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/china-genetic-testing-market
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
